This conference call transcript was computer generated and almost certianly contains errors. This transcript is provided for information purposes only.EarningsCall, LLC makes no representation about the accuracy of the aforementioned transcript, and you are cautioned not to place undue reliance on the information provided by the transcript.
Heron Therapeutics, Inc.
Q42022
3/23/2023
Operator
Conference Operator
Ladies and gentlemen, thank you for standing by. Welcome to the Heron Therapeutics Fourth Quarter 2022 Earnings Conference. As a reminder, this conference is being recorded, and now I would like to turn the call over to David Siqueiras, Executive Vice President, Chief Operating Officer.
David Siqueiras
Please proceed.
David Siqueiras
Executive Vice President and Chief Operating Officer
Thank you, Lisa. Good afternoon, everyone, and thank you for joining us.
You're reading a preview of the HRTX Q4 2022 earnings call.
Free account.
Disclaimer